Enprostil
Star0
Identification
- Generic Name
- Enprostil
- DrugBank Accession Number
- DB13824
- Background
-
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
-
- Weight
-
Average: 400.471
Monoisotopic: 400.188588622 - Chemical Formula
- C23H28O6
- Synonyms
-
- Enprostil
Pharmacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- 的体积分布
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
-
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAceclofenac The therapeutic efficacy of Enprostil can be decreased when used in combination with Aceclofenac. Acemetacin The therapeutic efficacy of Enprostil can be decreased when used in combination with Acemetacin. Acetylsalicylic acid The therapeutic efficacy of Enprostil can be decreased when used in combination with Acetylsalicylic acid. Alclofenac The therapeutic efficacy of Enprostil can be decreased when used in combination with Alclofenac. Aminophenazone The therapeutic efficacy of Enprostil can be decreased when used in combination with Aminophenazone. Antipyrine The therapeutic efficacy of Enprostil can be decreased when used in combination with Antipyrine. Antrafenine The therapeutic efficacy of Enprostil can be decreased when used in combination with Antrafenine. Balsalazide The therapeutic efficacy of Enprostil can be decreased when used in combination with Balsalazide. Benorilate The therapeutic efficacy of Enprostil can be decreased when used in combination with Benorilate. Benoxaprofen The therapeutic efficacy of Enprostil can be decreased when used in combination with Benoxaprofen. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Categories
- ATC Codes
- A02BB02 — Enprostil
- Drug Categories
-
- Alimentary Tract and Metabolism
- Anti-Ulcer Agents
- Autacoids
- Biological Factors
- Drugs for Acid Related Disorders
- Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
- Eicosanoids
- Fatty Acids
- Fatty Acids, Unsaturated
- Gastrointestinal Agents
- Inflammation Mediators
- Lipids
- Prostaglandins
- Prostaglandins E, Synthetic
- Prostaglandins, Synthetic
- Chemical TaxonomyProvided byClassyfire
-
- Description
- This compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Phenol ethers
- Sub Class
- Not Available
- Direct Parent
- Phenol ethers
- Alternative Parents
- Phenoxy compounds/Fatty acid methyl esters/Alkyl aryl ethers/Cyclopentanols/Methyl esters/Cyclic ketones/Cyclic alcohols and derivatives/Monocarboxylic acids and derivatives/Organic oxides/沪元drocarbon derivatives
- Substituents
- Alcohol/Alkyl aryl ether/Aromatic homomonocyclic compound/Carbonyl group/Carboxylic acid derivative/Carboxylic acid ester/Cyclic alcohol/Cyclic ketone/Cyclopentanol/Ether
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- J4IP5Z9DAU
- CAS number
- 73121-56-9
- InChI Key
- PTOJVMZPWPAXER-FPXSIRDUSA-N
- InChI
-
InChI=1S/C23H28O6/c1-28-23(27)12-8-3-2-7-11-19-20(22(26)15-21(19)25)14-13-17(24)16-29-18-9-5-4-6-10-18/h3-7,9-10,13-14,17,19-20,22,24,26H,8,11-12,15-16H2,1H3/b14-13+/t2?,17-,19-,20-,22-/m0/s1
- IUPAC Name
-
methyl 7-[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl]hepta-4,5-dienoate
- SMILES
-
COC(=O)CCC=C=CC[C@H]1[C@H](\C=C\[C@H](O)COC2=CC=CC=C2)[C@@H](O)CC1=O
References
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
-
Property Value Source Water Solubility 0.0149 mg/mL ALOGPS logP 2.58 ALOGPS logP 2.59 Chemaxon logS -4.4 ALOGPS pKa (Strongest Acidic) 13.99 Chemaxon pKa (Strongest Basic) -2.9 Chemaxon Physiological Charge 0 Chemaxon 沪元drogen Acceptor Count 5 Chemaxon 沪元drogen Donor Count 2 Chemaxon Polar Surface Area 93.06 Å2 Chemaxon Rotatable Bond Count 11 Chemaxon Refractivity 111.36 m3·mol-1 Chemaxon Polarizability 43.51 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon 医学博士DR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
-
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at June 23, 2017 20:49 / Updated at February 21, 2021 18:54